Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1044]
News [2637]
Articles [170]
Editorials [8]
Conferences [107]
elearning [25]
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis...
Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer ( Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK )
8 Feb 2018
Focus on screening, not biomarkers
Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands
Focus on screening, not biomarkers ( Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands )
14 Dec 2017
Effective implementation of personalised medicine guidelines
Prof James N'Dow - European Association of Urology (EAU), Arnhem, The...
Effective implementation of personalised medicine guidelines ( Prof James N'Dow - European Association of Urology (EAU), Arnhem, The Netherlands )
11 Dec 2017
Editor's Choice for November 2017
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for November 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Dec 2017
Prostate cancer in sub-Saharan Africa
Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA
Prostate cancer in sub-Saharan Africa ( Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA )
21 Nov 2017
Editor's Choice for September 2017
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for September 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
27 Sep 2017
Bladder cancer's relationship with the urinary and gut microbiomes
Dr Jeremy Burton - Lawson Health Research Institute, London, Canada
Bladder cancer's relationship with the urinary and gut microbiomes ( Dr Jeremy Burton - Lawson Health Research Institute, London, Canada )
21 Sep 2017
ESMO 2017 roundup with Dr Bishal Gyawali (1/2)
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (1/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017
Nivolumab and ipilimumab for metastatic kidney cancer
Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France
Nivolumab and ipilimumab for metastatic kidney cancer ( Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France )
11 Sep 2017
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma
Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA )
10 Sep 2017
RANGE trial of ramucirumab for urothelial cancer
Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA
RANGE trial of ramucirumab for urothelial cancer ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA )
10 Sep 2017
Phase Ib/II trial of combination PD-1 therapy against kidney cancer
Dr Chung-Han Lee - Memorial Sloan Kettering Cancer Center, New York, USA
Phase Ib/II trial of combination PD-1 therapy against kidney cancer ( Dr Chung-Han Lee - Memorial Sloan Kettering Cancer Center, New York, USA )
9 Sep 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation